CUTR - キュテラ (Cutera Inc.) キュテラ

 CUTRのチャート


 CUTRの企業情報

symbol CUTR
会社名 Cutera Inc (キュテラ)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Electromedical_Electrotherapeutic Apparatus  
業種 先端医療機器_テクノロジ―   医療関連(Health Care)
概要 事業概要 キュテラ(Cutera Inc.)は医療機器会社である。同社は世界中の開業医に提供するレーザーおよびその他のエネルギーベース美容システムの設計、開発、製造、マーケティング、サービスを行う。同社は医師や他の開業医が美容整形の実行を可能にするenlighten、excel HR、truSculpt、excel Vとxeoなどを含む製品プラットフォームを提供する。同社の各レーザーと光ベースのプラットフォームは1つまたは複数のハンドピース、及び1つのグラフィック?ユーザー?インターフェース、1つのレーザーや光ベースのモジュール、制御システムソフトウェアおよび高電圧電子機器を内蔵した1つのコンソールで構成される。同社もCV、ExcelとVantageを含むCoolGlide、Titan S、ProWave 770、OPS 600、LP560、AcuTip 500、Titan V/XLとLimeLightを含むSolera、及び日本市場向けの第三者ソースシステムmyQを提供する。   キュテラは、米国の医療機器メ―カ―。レ―ザ―光治療器をはじめとする医療機器の設計、開発、製造、販売、修理などを行う。主な製品は、美容医療治療器「ゼオ」、爪水虫治療器「ジェネシス・プラス」、部分痩身器「トゥル―・スカルプ」など。本社は、カリフォルニア州ブリスベン。   
本社所在地 3240 Bayshore Blvd. Brisbane CA 94005 USA
代表者氏名 J. Daniel Plants J.ダニエル・プラント
代表者役職名 Independent Chairman of the Board
電話番号 +1 415-657-5500
設立年月日 36008
市場名 NASDAQ National Market System
ipoyear 2004年
従業員数 367人
url www.cutera.com
nasdaq_url https://www.nasdaq.com/symbol/cutr
adr_tso
EBITDA EBITDA(百万ドル) 0.92300
終値(lastsale) 21.435
時価総額(marketcap) 296591808
時価総額 時価総額(百万ドル) 279.22660
売上高 売上高(百万ドル) 162.48300
企業価値(EV) 企業価値(EV)(百万ドル) 250.22160
当期純利益 当期純利益(百万ドル) 32.76400
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Cutera Inc. revenues increased 17% to $76.7M. Net loss totaled $3.6M vs. income of $925K. Revenues reflect United States segment increase of 21% to $49.3M. Net loss reflects Selling General_Admin increase of 21% to $27.5M (expense) General_admin exp increase of 49% to $8.5M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from $0.07 to -$0.26.

 CUTRのテクニカル分析


 CUTRのニュース

   Skin Tightening Market New Technology, Competitive Analysis and Opportunities 2027 | Cutera, Alma Lasers, BRERA MEDICAL TECHNOLOGIES, Pollogen, Cynosure  2021/01/13 07:55:24 OpenPR
The global skin tightening market is expected to reach US$ 2,350.22 million in 2027 from US$ 1,350.40 million in 2019. The market is estimated to grow with a CAGR of 7.3% from 2020 to 2027. In terms of product type the
   Skincare Devices Market 2026 Worldwide Trends in New Research Report - Syneron Medical, Alma Laser, Cutera, GE Healthcare, Human Med AG, Michelsong Diagnotics  2021/01/11 11:56:28 OpenPR
Skincare Devices market is evaluated based on two segments i.e., by type and application and covers essential statistics and details for current and future market scenarios. The report actively includes informative aspects relating to product developments, launches, and trends, to
   Laser Hair Loss Devices Market Size, Share 2021: Research during the Ongoing COVID-19 Pandemic, Growth and Research Methodology by Syneron Medical, Alma Lasers, Cutera, LUTRONIC, Solta Medical  2021/01/06 10:39:39 OpenPR
DBMR published a new study on the Global Laser Hair Loss Devices Market exclusive insights, Opportunities and revenue size estimation and growth factors. Laser Hair Loss Devices Market 2020 Report considers important aspects of the market that consist of historic
   Skin Aesthetic Devices Market Top Players- LUMENIS, Cutera inc., Merz Pharma, Candela Corporation  2020/12/18 08:13:03 OpenPR
According to The Insight Partners market research study titled ‘Skin Aesthetic Devices Market - Global Analysis and Forecasts by Product, treatment and End User,the global skin aesthetic devices market is expected to reach US$ 4,332.90 Mn in 2027 from US$
   Dermatology Treatment Devices Market Top Players- Cutera Inc.; Bausch Health Companies Inc.; Sciton, Inc.  2020/12/16 08:14:51 OpenPR
The dermatology treatment devices market is expected to reach US$ 8,800.07 million in by2027 from US$ 5,320.73 million in 2019;. The market it is estimated to grow with ata CAGR of 6.7% from 2020- to 2027. Factors such as rising prevalence
   Cutera to Present at the UBS Global Healthcare Conference  2020/05/18 20:01:00 Business Wire
BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (CUTR) (“Cutera” or the “Company”), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today announced that it will present at the Virtual UBS Global Healthcare Conference at 1:20pm ET on Wednesday, May 20, 2020. Presenting will be Dave Mowry, Chief Executive Officer, and Fuad Ahmad, Interim Chief Financial Officer. The presentation will be webcast and can be accessed from the Investor Relations secti
   Cutera, Inc. Announces Closing of Public Stock Offering and Full Exercise of Underwriter’s Option to Purchase Additional Stock  2020/04/21 20:24:00 Business Wire
BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (NASDAQ: CUTR) (“Cutera”), a provider of laser and other energy-based aesthetic systems for practitioners worldwide, today announced the closing of its previously announced underwritten public offering of 2,742,750 shares of its common stock at a public offering price of $10.50 per share, which includes the exercise in full of the underwriter’s option to purchase up to an additional 357,750 shares of its common stock at the same price per share to
   Cutera, Inc. Announces Pricing of Public Offering of Common Stock  2020/04/17 02:12:00 Business Wire
BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (NASDAQ: CUTR) (“Cutera”), a provider of laser and other energy-based aesthetic systems for practitioners worldwide, today announced the pricing of an underwritten public offering of 2,385,000 shares of its common stock at a public offering price of $10.50 per share. The offering is expected to close on or about April 21, 2020, subject to the satisfaction of customary closing conditions. In connection with the offering, Cutera has granted the unde
   Cutera, Inc. Announces Proposed Public Offering of Common Stock  2020/04/16 20:04:00 Business Wire
Cutera, Inc. (NASDAQ: CUTR) (“Cutera”), a provider of laser and other energy-based aesthetic systems for practitioners worldwide, today announced that
   Cutera, Inc. Announces Fourth Quarter and Full-Year 2019 Financial Results  2020/02/26 21:10:00 Business Wire
BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (NASDAQ: CUTR) (“Cutera” or the “Company”), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today reported financial results for the fourth quarter and full year ended December 31, 2019. Fourth Quarter 2019 Financial and Operational Highlights Revenue was $51.8 million, an increase of 14% over the prior-year period, driven by: truSculpt portfolio revenue growth of 52% Recurring revenue growth of 28
   Cutera, Inc. Announces Closing of Public Stock Offering and Full Exercise of Underwriter’s Option to Purchase Additional Stock  2020/04/21 20:24:00 Business Wire
BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (NASDAQ: CUTR) (“Cutera”), a provider of laser and other energy-based aesthetic systems for practitioners worldwide, today announced the closing of its previously announced underwritten public offering of 2,742,750 shares of its common stock at a public offering price of $10.50 per share, which includes the exercise in full of the underwriter’s option to purchase up to an additional 357,750 shares of its common stock at the same price per share to
   Cutera, Inc. Announces Pricing of Public Offering of Common Stock  2020/04/17 02:12:00 Business Wire
BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (NASDAQ: CUTR) (“Cutera”), a provider of laser and other energy-based aesthetic systems for practitioners worldwide, today announced the pricing of an underwritten public offering of 2,385,000 shares of its common stock at a public offering price of $10.50 per share. The offering is expected to close on or about April 21, 2020, subject to the satisfaction of customary closing conditions. In connection with the offering, Cutera has granted the unde
   Cutera, Inc. Announces Proposed Public Offering of Common Stock  2020/04/16 20:04:00 Business Wire
Cutera, Inc. (NASDAQ: CUTR) (“Cutera”), a provider of laser and other energy-based aesthetic systems for practitioners worldwide, today announced that
   Cutera, Inc. Announces Fourth Quarter and Full-Year 2019 Financial Results  2020/02/26 21:10:00 Business Wire
BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (NASDAQ: CUTR) (“Cutera” or the “Company”), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today reported financial results for the fourth quarter and full year ended December 31, 2019. Fourth Quarter 2019 Financial and Operational Highlights Revenue was $51.8 million, an increase of 14% over the prior-year period, driven by: truSculpt portfolio revenue growth of 52% Recurring revenue growth of 28
   Cutera, Inc. to Announce Fourth Quarter and Full-Year 2019 Results on February 26, 2020  2020/02/13 21:41:00 Business Wire
BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of laser and energy-based aesthetic systems for practitioners worldwide, today announced that it will report financial results for the fourth quarter and full-year 2019 after the market close on Wednesday, February 26, 2020. The Company’s management will host a conference call to discuss these results and related matters at 1:30 p.m. PT (4:30 p.m. ET) that same day. Participating on th

 関連キーワード  (先端医療機器_テクノロジ― 米国株 キュテラ CUTR Cutera Inc.)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)